real word drugs
PreclinicalSmall molecule
real word drugs is one of 9 small molecule programs targeting Familial Mediterranean Fever. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Familial Mediterranean Fever
#DrugCompanyPhaseTrials
1Colcrys
Alnylam PharmaceuticalsApproved
Kineret
SSwedish Orphan Biovitrum
Approved
Kineret
AmgenPhase 3
Actemra
RochePhase 2
Arcalyst
KKiniksa Pharmaceuticals (UK), Ltd.
Phase 2
RPH-104
UUnknown Sponsor
Phase 2
RIST4721
AAristea Therapeutics, Inc.
Phase 2
Ilaris
NovartisPreclinical
real word drugs
TTongji Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for real word drugs. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- TTongji Hospital